Megan Garrity-Park

Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma†

Jinping Lai, Dalbir S. Sandhu, Chunrong Yu et al. · Hepatology · 2008 · 206 citations · Full text

Medicine, Molecular Biology, Oncology +17

Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury

ES Baskin-Bey, Kenneth Washburn, Sandy Feng et al. · American Journal of Transplantation · 2006 · 179 citations · Full text

Medicine, Pharmacology, Apoptosis +12

Upregulation of DNA Methyltransferase–Mediated Gene Silencing, Anchorage-Independent Growth, and Migration of Colon Cancer Cells by Interleukin-6

Eílis Foran, Megan Garrity-Park, Coralie Mureau et al. · Molecular Cancer Research · 2010 · 154 citations · Full text

Medicine, Molecular Biology, Oncology +17

The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3–Dependent Wnt Activation

Jin-Ping Lai, Abdul M. Oseini, Catherine D. Moser et al. · Hepatology · 2010 · 118 citations · Full text

Life Sciences, Biochemistry, Oncology +17

SULF1 Inhibits Tumor Growth and Potentiates the Effects of Histone Deacetylase Inhibitors in Hepatocellular Carcinoma

Jinping Lai, Chunrong Yu, Catherine D. Moser et al. · Gastroenterology · 2006 · 79 citations · Full text

Medicine, Oncology, Pharmacology +14